Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

NCT06604442 is registered in ClinicalTrials.gov with Blue Earth Diagnostics as lead sponsor.

NCT NCT06604442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06604442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
Lead sponsor
Blue Earth Diagnostics
Phase
Phase 4
Overall status
Completed
Start date
December 4, 2024
Completion date
August 29, 2025
Enrollment
62 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer